BioGaia AB to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / BioGaia AB (FRA:BGL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 4, 2021 at 9:30 AM Easte...
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
11.5 | |
11.5 | |
- | |
11.5 | |
11.5 | |
8.0773-12.08 | |
1 133 M | |
29.4872 | |
97 454 K | |
1 369 M | |
0.1028 | |
0.0557 | |
0.545 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / BioGaia AB (FRA:BGL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 4, 2021 at 9:30 AM Easte...
NEW YORK, NY / ACCESSWIRE / February 4, 2021 / BioGaia AB (FRA:BGL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 4, 2021 at 9:30 AM Easte...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: